• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biosaf Health . Genetic differentiation and diversity of SARS-CoV-2 omicron variant in Its early outbreak

tetano

Editor, Senior Moderator
Biosaf Health


. 2022 Apr 25.
doi: 10.1016/j.bsheal.2022.04.004. Online ahead of print.
Genetic differentiation and diversity of SARS-CoV-2 omicron variant in Its early outbreak


Shenghui Weng[SUP] 1 2 [/SUP], Jingzhe Shang[SUP] 1 2 [/SUP], Yexiao Cheng[SUP] 1 2 [/SUP], Hangyu Zhou[SUP] 1 2 [/SUP], Chengyang Ji[SUP] 1 2 [/SUP], Rong Yang[SUP] 1 2 [/SUP], Aiping Wu[SUP] 1 2 [/SUP]



Affiliations

Abstract

The recently emerged Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has quickly spread to most countries. Although many consensus mutations of the Omicron variant have been recognized, little is known about its genetic variation during its transmission in the population. Here, we comprehensively analyzed the genetic differentiation and diversity of the Omicron variant during its early outbreak. We found that Omicron achieved more structural variations, especially deletions, on the SARS-CoV-2 genome than the other four variants of concern (Alpha, Beta, Gamma, and Delta) in the same timescale. In addition, the Omicron variant acquired, except for 50 consensus mutations, seven great new non-synonymous nucleotide substitutions during its spread. Three of them are on the S protein, including S_A701V, S_L1081V, and S_R346K, which belong to the receptor-binding domain (RBD). The Omicron BA.1 branch could be divided into five divergent groups spreading across different countries and regions based on these seven novel mutations. Furthermore, we found that the Omicron variant possesses more mutations related to a faster transmission rate than the other SARS-CoV-2 variants by assessing the relationship between the genetic diversity and transmission rate; the findings indicated that more attention should be paid to the significant genetic differentiation and diversity of the Omicron variant for better disease prevention and control.

Keywords: Genetic Diversity; Omicron; SARS-CoV-2.
 
Back
Top Bottom